360Dx4 天
AliveDx Submits Autoimmune Disease Test for FDA 510(k) Clearance
The Switzerland-based firm's MosaiQ AiPlex Connective Tissue Diseases (CTDplus) assay is used to aid the diagnosis of autoimmune diseases.
AliveDx announces US FDA 510(k) submission for MosaiQ AiPlex® Connective Tissue Diseases ...
AliveDx announces it has submitted 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for the ...